Individuals with existing comorbidities like diabetes, hypertension, hyperlipidaemia, obstructive sleep apnoea (OS), heart attack, stroke, and blood vessel disorders
Individuals with very low body weight (relative to typical GLP-1 trial populations) may also benefit
Some protocols incorporate Trenbolone, which provides unmatched muscle preservation and fat loss during caloric restriction
traditional weight loss, its essential to understand how conventional approaches have shaped weight loss efforts for decades
GLP-1 receptor agonist drugs are large peptide molecules, around 3,000-4,000 Daltons, making the weight loss efficacy of GLP-1 patches ambiguous
When all criteria for binge-eating disorder are met except that binge eating occurs less frequently or for a shorter duration, the diagnosis is a subtype of OSFED known as BED of low frequency and/or limited duration